RPAM
Rhenman & Partners Asset Management’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Hold |
104,250
| – | – | 0.44% | 60 |
|
|
2025
Q1 | $4.19M | Sell |
104,250
-45,000
| -30% | -$1.81M | 0.48% | 50 |
|
|
2024
Q4 | $7.02M | Sell |
149,250
-31,250
| -17% | -$1.47M | 0.72% | 48 |
|
|
2024
Q3 | $9.53M | Sell |
180,500
-17,015
| -9% | -$898K | 0.77% | 45 |
|
|
2024
Q2 | $10.7M | Hold |
197,515
| – | – | 1.03% | 35 |
|
|
2024
Q1 | $13.8M | Buy |
197,515
+47,603
| +32% | +$3.34M | 1.31% | 29 |
|
|
2023
Q4 | $12.5M | Sell |
149,912
-50,088
| -25% | -$4.18M | 1.25% | 30 |
|
|
2023
Q3 | $5.89M | Hold |
200,000
| – | – | 0.64% | 46 |
|
|
2023
Q2 | $6.52M | Sell |
200,000
-5,000
| -2% | -$163K | 0.69% | 48 |
|
|
2023
Q1 | $7.01M | Sell |
205,000
-11,322
| -5% | -$387K | 0.77% | 42 |
|
|
2022
Q4 | $9.91M | Buy |
216,322
+6,322
| +3% | +$290K | 1.03% | 37 |
|
|
2022
Q3 | $9.17M | Sell |
210,000
-20,000
| -9% | -$873K | 0.96% | 39 |
|
|
2022
Q2 | $9.04M | Sell |
230,000
-65,000
| -22% | -$2.55M | 1.03% | 38 |
|
|
2022
Q1 | $10.9M | Buy |
295,000
+145,000
| +97% | +$5.34M | 1.07% | 38 |
|
|
2021
Q4 | $6.84M | Buy |
+150,000
| New | +$6.84M | 0.45% | 62 |
|